Antitumor agent-77

Antitumor agent-77 具有抗肿瘤活性,能抑制癌细胞生长和迁移,并通过抑制 GPx-4 和升高 COX2 引发铁死亡 (ferroptosis),同时还能激活肿瘤细胞固有凋亡通路 (Bax-Bcl-2-caspase-3),阻碍肿瘤细胞上皮间质转化 (EMT) 过程。
产品编号: MS-B87828 CAS No.: 2870703-21-0 分子式: C7H11F3N2O5Pt 分子量: 455.25
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Antitumor agent-77 具有抗肿瘤活性,能抑制癌细胞生长和迁移,并通过抑制 GPx-4 和升高 COX2 引发铁死亡 (ferroptosis),同时还能激活肿瘤细胞固有凋亡通路 (Bax-Bcl-2-caspase-3),阻碍肿瘤细胞上皮间质转化 (EMT) 过程。

生物实验数据

生物活性 Antitumor agent-77 exhibits antitumor activity by inhibiting cancer cell growth and migration, induces ferroptosis through the inhibition of GPx-4 and elevation of COX2, and also activates the intrinsic apoptotic pathway (Bax-Bcl-2-caspase-3) in tumor cells while impeding the epithelial-mesenchymal transition (EMT) process.
IC50 & Target

COX-2

 

Bax

 

Bcl-2

 

体外研究
(In Vitro)

Antitumor agent-77 (compound 2a) (30 μM; 4 h) exhibits better solubility and improved cellular uptake than Carboplatin.html" class="link-product" target="_blank">Carboplatin (MS-L77931) in A549 cells.
Antitumor agent-77 (20 μM; 36 h) produces cytotoxicity by inducing apoptosis of A549 cancer cells.
Antitumor agent-77 (20 μM; 24 h) results in significant down-regulation of Bcl-2 and upregulation of Bax, also leads to E-cadherin increase, Vimentin decrease.
Antitumor agent-77 (20 μM; 24 h) arrests cell cycle at S phase and G2/M phase.
Antitumor agent-77 (10 μM; 12 h) inhibits cells migration with inhibition rate of 52%.

Apoptosis Analysis

Cell Line: A549 cells
Concentration: 20 μM
Incubation Time: 36 hours
Result: Resulte cell apopsotsis with average apoptotic values (including both early and late apoptotic states which were displayed in Q1-LR and Q1-UR, respectively) of 25.34%.

Western Blot Analysis

Cell Line: A549 cells
Concentration: 20 μM
Incubation Time: 24 hours
Result: Elevated the level of cleaved caspase-3 and reduced the level of caspase-3 in A549 cells.
Decreased anti-apoptotic protein Bcl-2 and increased pro-apoptotic protein Bax.
Elevated the expression of E-cadherin and on the other hand, lowered the protein level of Vimentin.

Cell Cycle Analysis

Cell Line: A549 cells
Concentration: 20 μM
Incubation Time: 24 hours
Result: Blocked cell cycle progression in S and G2/M phase with the values of 41.11% and 26.03%, respectively.
体内研究
(In Vivo)

Antitumor agent-77 (compound 2a) (6 μg/kg; i.v.; injected on day 8, 10, 12) exhibits similar potency compared with Oxaliplatin.html" class="link-product" target="_blank">Oxaliplatin (MS-L84463), without significant damage to kidney and liver as well as weight loss.

Animal Model: A549 xenograft models in mouse
Dosage: 6 μg/kg
Administration: Intravenous injection; administration on day 8, 10, 12 after establishing xenograft models (A549 cells; s.c.)
Result: Significantly repressed tumor growth, and maintained normal kidney and liver architecture in mice.

化学信息

分子量 455.25
分子式 C7H11F3N2O5Pt
CAS No. 2870703-21-0

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础